IgG replacement therapy leads to reduced expression of Ki67, CD38, and HLA-DR on CD8 T cells (22), indicating that IgG replacement may help control infections or infection-associated factors that are implicated in chronic activation of the CD8 T cells. The gene discussed is CD8A; the disease is infection.